Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience

NCT04341103 is registered in ClinicalTrials.gov with CareDx as lead sponsor.

NCT NCT04341103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Lead sponsor
CareDx
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
March 1, 2021
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, solid organ transplant rejection